Compile Data Set for Download or QSAR
Report error Found 133 for UniProtKB: Q14498
TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659489(US20240092770, Compound 94)
Affinity DataEC50:  45.2nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659522(US20240092770, Compound 135)
Affinity DataEC50:  47nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659549(US20240092770, Compound 198)
Affinity DataEC50:  47nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659447(US20240092770, Compound 42)
Affinity DataEC50:  55.2nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659478(US20240092770, Compound 81)
Affinity DataEC50:  55.6nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659432(US20240092770, Compound 10)
Affinity DataEC50:  75.7nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659487(US20240092770, Compound 91)
Affinity DataEC50:  76.6nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659482(US20240092770, Compound 85)
Affinity DataEC50:  95.9nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659451(US20240092770, Compound 47)
Affinity DataEC50:  97nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659508(US20240092770, Compound 117)
Affinity DataEC50:  99.6nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659490(US20240092770, Compound 95)
Affinity DataEC50:  104nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659491(US20240092770, Compound 97)
Affinity DataEC50:  105nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659480(US20240092770, Compound 83)
Affinity DataEC50:  105nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659429(US20240092770, Compound 7)
Affinity DataEC50:  106nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659433(US20240092770, Compound 11)
Affinity DataEC50:  108nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659452(US20240092770, Compound 48)
Affinity DataEC50:  125nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659497(US20240092770, Compound 104)
Affinity DataEC50:  128nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659555(US20240092770, Compound 204)
Affinity DataEC50:  130nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659439(US20240092770, Compound 32)
Affinity DataEC50:  136nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659455(US20240092770, Compound 51)
Affinity DataEC50:  164nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659509(US20240092770, Compound 118)
Affinity DataEC50:  168nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659485(US20240092770, Compound 89)
Affinity DataEC50:  174nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659481(US20240092770, Compound 84)
Affinity DataEC50:  175nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659453(US20240092770, Compound 49)
Affinity DataEC50:  190nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659492(US20240092770, Compound 98)
Affinity DataEC50:  196nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659551(US20240092770, Compound 200)
Affinity DataEC50:  207nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659548(US20240092770, Compound 187)
Affinity DataEC50:  228nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659553(US20240092770, Compound 202)
Affinity DataEC50:  241nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659547(US20240092770, Compound 186)
Affinity DataEC50:  258nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659436(US20240092770, Compound 24)
Affinity DataEC50:  269nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659445(US20240092770, Compound 40)
Affinity DataEC50:  275nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659484(US20240092770, Compound 87)
Affinity DataEC50:  277nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659537(US20240092770, Compound 152)
Affinity DataEC50:  281nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659435(US20240092770, Compound 13)
Affinity DataEC50:  298nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659498(US20240092770, Compound 105)
Affinity DataEC50:  299nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659440(US20240092770, Compound 34)
Affinity DataEC50:  301nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659456(US20240092770, Compound 55)
Affinity DataEC50:  302nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659499(US20240092770, Compound 107)
Affinity DataEC50:  325nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659468(US20240092770, Compound 70)
Affinity DataEC50:  338nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659536(US20240092770, Compound 151)
Affinity DataEC50:  344nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659441(US20240092770, Compound 36)
Affinity DataEC50:  354nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659510(US20240092770, Compound 120)
Affinity DataEC50:  359nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659446(US20240092770, Compound 41)
Affinity DataEC50:  363nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659494(US20240092770, Compound 100)
Affinity DataEC50:  364nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659434(US20240092770, Compound 12)
Affinity DataEC50:  384nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659486(US20240092770, Compound 90)
Affinity DataEC50:  389nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659552(US20240092770, Compound 201)
Affinity DataEC50:  391nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659450(US20240092770, Compound 45)
Affinity DataEC50:  394nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659557(US20240092770, Compound 215)
Affinity DataEC50:  420nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659467(US20240092770, Compound 69)
Affinity DataEC50:  421nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
US Patent

Displayed 1 to 50 (of 133 total ) | Next | Last >>
Jump to: